Pamidronate: a novel treatment for the SAPHO syndrome?
Marshall, H., Bromilow, J., Thomas, A. L. and Arden, N. K. (2002) Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology, 41, (2), 231-233. (doi:10.1093/rheumatology/41.2.231-a).
Full text not available from this repository.
SIR, The SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis and osteitis) was first described by Chamot et al. in 1987. It can occur at any age but usually appears between childhood and middle age. The most troublesome symptom is bone pain, which most often affects the anterior chest wall. Dermatological features include pustulosis of the palms and soles, pustular psoriasis, acne conglobata or fulminans and hydradenitis suppurativa.
|Subjects:||R Medicine > RL Dermatology|
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Developmental Origins of Health and Disease
|Date Deposited:||24 Apr 2006|
|Last Modified:||02 Mar 2012 11:26|
|Contributors:||Marshall, H. (Author)
Bromilow, J. (Author)
Thomas, A. L. (Author)
Arden, N. K. (Author)
|Contact Email Address:||A.L.Thomas@soton.ac.uk|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)